About oritavancin
Lipoglycopeptide antibiotic
Used for
- Treats acute bacterial skin and skin-structure infections caused by susceptible bacteria, including certain resistant staphylococci.
Usual adult dose
Adults: 1,200 mg intravenously once, infused over 3 hours.
Common side effects
- Headache
- Nausea
- Vomiting
- Diarrhea
Important warnings
- May cause serious allergic or infusion reactions.
- Can interfere with certain blood-clotting laboratory tests for up to 120 hours.
- Avoid intravenous unfractionated heparin for 120 hours after treatment.
- Use only for proven or strongly suspected bacterial infections.
Pregnancy
Human pregnancy data are limited; use only when clearly needed.
Breastfeeding
It is unknown whether oritavancin passes into human milk; consider infant exposure and treatment benefits.
Interactions
- Warfarin: may alter clotting-test results; monitor anticoagulation appropriately.
- Intravenous unfractionated heparin is contraindicated for 120 hours after treatment.
- May affect tests measuring coagulation for up to 120 hours.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.